Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic

Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which needs to be administered regularly by a trained clinician every 3 months. The spread of the severe acute respiratory syndrome coronavirus-2 pandemic has forced many patients to momentarily stop the sch...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Baraldi, Carlo, Ornello, Raffaele, Favoni, Valentina, Sacco, Simona, Caponnetto, Valeria, Pierangeli, Giulia, Pani, Luca, Cevoli, Sabina, Guerzoni, Simona
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082239/
https://ncbi.nlm.nih.gov/pubmed/33935945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.647995
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares